🇺🇸 FDA
Patent

US 8211445

PSM peptides as vaccine targets against methicillin-resistant Staphylococcus

granted A61KA61K38/00A61K39/00

Quick answer

US patent 8211445 (PSM peptides as vaccine targets against methicillin-resistant Staphylococcus) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P31/04